Günter Burg

Q: What Schools Are Affiliated With Günter Burg

Günter Burg is affiliated with the following schools: Case Western Reserve University, University of Würzburg, University of Zurich

Günter Burg's AcademicInfluence.com Rankings

Günter Burg

Philosophy

#5706

World Rank

#8588

Historical Rank

Logic

#2938

World Rank

#4017

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Günter Burg's Degrees

Doctorate Medicine University of Vienna

Why Is Günter Burg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Günter Burg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

WHO-EORTC classification for cutaneous lymphomas. (2005) (3669)
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells (1998) (3018)
Severity Scoring of Atopic Dermatitis: The SCORAD Index (1993) (1829)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). (2007) (1063)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production (2005) (1010)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. (2006) (457)
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. (2002) (423)
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. (2004) (374)
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects (2005) (327)
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. (1991) (280)
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. (1999) (262)
Interleukin‐10 is a growth factor for human melanoma cells and down‐regulates HLA class‐I, HLA class‐II and ICAM‐1 molecules (1997) (258)
Clinicopathological spectrum of mycosis fungoides (2004) (254)
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients (1995) (220)
Primary cutaneous melanoma. Prognostic classification of anatomic location (1995) (211)
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. (2001) (205)
Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. (1989) (199)
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). (1996) (185)
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. (2005) (182)
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. (1997) (180)
A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X‐rays (2002) (171)
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. (2003) (169)
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients (2004) (162)
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification (1995) (160)
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). (2008) (158)
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. (1998) (153)
A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. (1991) (153)
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. (2005) (148)
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. (2004) (147)
Serum S100--a marker for disease monitoring in metastatic melanoma. (1997) (146)
Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. (1975) (143)
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients (2004) (137)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. (2003) (132)
Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. (2000) (131)
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. (2001) (129)
Superficial radiotherapy for patients with basal cell carcinoma (2003) (127)
Reduction of tumor burden and stabilization of disease by systemic therapy with anti‐CD20 antibody (rituximab) in patients with primary cutaneous B‐cell lymphoma (2000) (126)
Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis (2005) (126)
Absence of p53 gene mutations in cutaneous melanoma. (1994) (113)
Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. (1998) (109)
Baseline staging in cutaneous malignant melanoma (2004) (109)
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. (1992) (108)
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. (2004) (107)
Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. (2010) (103)
Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. (2002) (102)
Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil‐rich CD30+ anaplastic large‐cell lymphoma. Clinicopathological study of four cases and review of the literature (2003) (101)
New Trends in Allergy III (1986) (96)
Pityriasis rosea is not associated with human herpesvirus 7. (1999) (96)
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. (2000) (95)
Drug-induced lichen planus. (1998) (93)
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. (2000) (92)
"Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. (1990) (90)
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. (2003) (88)
Human dermal dendritic cells process and present soluble protein antigens. (1998) (88)
Nephrogenic Fibrosing Dermopathy Treated with Extracorporeal Photopheresis (2004) (88)
A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. (1996) (84)
Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. (1986) (83)
Updated Swiss Guidelines for the Treatment and Follow-Up of Cutaneous Melanoma (2004) (81)
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop (2015) (80)
From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. (2001) (79)
TAP1 down‐regulation in primary melanoma lesions: An independent marker of poor prognosis (2001) (78)
Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. (2001) (76)
Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration into the Skin, but Normal Extravasation into Visceral Organs1 (2002) (74)
Imiquimod in basal cell carcinoma: how does it work? (2003) (73)
Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. (2000) (71)
Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? (2002) (71)
Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. (1993) (71)
A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time. (2000) (70)
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? (1995) (69)
Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. (1993) (68)
Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers (2004) (68)
New perspectives on immunobiology and immunotherapy of melanoma. (1999) (66)
Small plaque (digitate) parapsoriasis is an 'abortive cutaneous T-cell lymphoma' and is not mycosis fungoides. (1995) (66)
Pseudo-Melanoma after Laser Therapy (1998) (65)
Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? (2004) (64)
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. (1996) (64)
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. (2003) (64)
Skin irritant reactivity following experimental cumulative irritant contact dermatitis (1994) (64)
CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. (2005) (62)
Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. (1998) (62)
Intra-lesional low-dose interferon α2a therapy for primary cutaneous marginal zone B-cell lymphoma (2006) (61)
Syringolymphoid hyperplasia with alopecia--a syringotropic cutaneous T-cell lymphoma? (1992) (61)
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. (2003) (60)
Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. (2001) (60)
Fascin expression in CD30‐positive cutaneous lymphoproliferative disorders (2002) (60)
Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. (2000) (59)
Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. (1997) (58)
Questions to the editorial board and other authorities (1982) (57)
Expression of apoptosis regulators in cutaneous T‐cell lymphoma (CTCL) cells (2003) (57)
Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. (1999) (56)
Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept (2002) (56)
Survival and Prognostic Factors in Patients with Brain Metastases from Malignant Melanoma (2004) (56)
HPV-11- and HPV-16-associated oral verrucous carcinoma. (1996) (56)
Mycosis fungoides with Mucinosis follicularis in Childhood (1999) (55)
Imiquimod Induces Complete Clearance of a PUVA-Resistant Plaque in Mycosis fungoides (2003) (55)
No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma. (1997) (55)
Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. (1996) (55)
Pathogenesis of cutaneous lymphomas. (2000) (55)
Multilineage progression of genetically unstable tumor subclones in cutaneous T‐cell lymphoma (2004) (54)
Blastic natural killer‐cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? (2003) (54)
Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. (1984) (53)
Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. (1995) (53)
Comparative analysis of histologicai and immunohistological features in mycosis fungoides and Sézary syndrome (1998) (52)
Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors (2000) (52)
Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool. (1995) (51)
Treatment of Vascular Lesions Using the VersaPulse® Variable Pulse Width Frequency Doubled Neodymium:YAG Laser (1998) (50)
Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. (1993) (50)
Acute generalized exanthematous pustulosis due to doxycycline. (1993) (49)
Classification of cutaneous lymphomas. (1994) (49)
Allergic contact dermatitis from natural latex without contact urticaria (1993) (49)
Detection of clonal rearrangement of T‐cell receptor genes in the diagnosis of primary cutaneous CD30+ lymphoproliferative disorders (2006) (49)
Pathology of cutaneous T-cell lymphoma. (1995) (49)
Micrographic Surgery (‘Slow Mohs’) in Cutaneous Sarcomas (1999) (48)
Therapy of Cutaneous Lymphoma – Current Practice and Future Developments (2003) (47)
Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. (1987) (47)
Galectin-1–Mediated Apoptosis in Mycosis Fungoides: The Roles of CD7 and Cell Surface Glycosylation (2003) (47)
A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin‐2 for metastatic melanoma. Clinical data and immunomonitoring (1995) (47)
Teledermatology as a new tool in sub-saharan Africa: an experience from Tanzania. (2000) (47)
Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7– T lymphocyte subsets in Sézary syndrome (1999) (47)
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. (1978) (46)
Trends in allergic contact sensitization (1988) (46)
Letters to Dermatology (1998) (46)
Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. (1990) (45)
Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. (2004) (45)
CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. (2000) (44)
Syringocystadenoma Papilliferum: A Study of Potential Tumor Suppressor Genes (2001) (44)
Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). (2001) (44)
Tumor regression of human and murine melanoma after intratumoral injection of IL‐12‐encoding plasmid DNA in mice (2002) (43)
Detection of Melanoma Relapse: First Comparative Analysis on Imaging Techniques versus S100 Protein (2006) (41)
Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? (1992) (41)
Teledermatology: Just Cool or a Real Tool? (2005) (40)
IL‐12 directly up‐regulates the expression of HLA class I, HLA class II and ICAM‐1 on human melanoma cells: a mechanism for its antitumor activity? (1999) (40)
Fatal, penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa). (1983) (40)
The use of anti‐T‐cell receptor‐Vβ antibodies for the estimation of treatment success and phenotypic characterization of clonal T‐cell populations in cutaneous T‐cell lymphomas (2002) (40)
Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. (1999) (39)
Discoid lupus erythematosus‐like lesions in carriers of X‐linked chronic granulomatous disease (1990) (39)
Granulomatous Slack Skin in Childhood (1997) (39)
Experimentally induced chronic irritant contact dermatitis to evaluate the efficacy of protective creams in vivo. (1999) (39)
Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. (2003) (39)
Superficial Acral Fibromyxoma: Report of Two Cases (2002) (39)
From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. (2002) (38)
Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. (1992) (38)
Swiss Guidelines for the Treatment and Follow-Up of Cutaneous Melanoma (2001) (38)
Pityriasis rosea – a virus-induced skin disease? An update (2000) (37)
Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long‐term follow‐up and review of the literature (2002) (37)
Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature (1999) (37)
Imiquimod Treatment Induces Expression of Opioid Growth Factor Receptor (2004) (37)
Cutaneous B-cell lymphoma. (1985) (36)
Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. (1984) (36)
Leg Ulcers in Patients with Myeloproliferative Disorders: Disease- or Treatment-Related? (2000) (36)
Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. (2000) (35)
Excimer Laser versus Narrow-Band UVB (311 nm) in the Treatment of Psoriasis Vulgaris (2006) (35)
Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). (1998) (35)
A realistic approach to the sensitivity of PCR‐DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T‐cell proliferations (1997) (35)
Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. (2001) (35)
Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. (1988) (34)
Pagetoid reticulosis. A further case report with a review of the literature. (1979) (34)
Cutaneous malignant lymphomas: Update 2006 (2006) (33)
Serological Immunomarkers in Cutaneous T Cell Lymphoma (2004) (33)
Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5. (1997) (33)
Revival of the Use of Botulinum Toxin: Application in Dermatology (2000) (33)
Expression of cancer/testis antigens in cutaneous T cell lymphomas (2002) (33)
Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm (2004) (33)
Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'. (1978) (33)
Analysis ofras mutations in human melanocytic lesions: activation of theras gene seems to be associated with the nodular type of human malignant melanoma (2005) (32)
HLA‐G expression in basal cell carcinomas of the skin recurring after radiotherapy (2005) (32)
Differentiation Between Pseudolymphomas and Malignant B Cell Lymphomas of the Skin (1982) (31)
Photochemotherapie kutaner Lymphome (1977) (31)
Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. (2003) (31)
Eruptive vellus hair cyst and steatocystoma multiplex: hybrid cysts. (1996) (31)
Hepatitis C and G viruses in B‐cell lymphomas of the skin (2003) (31)
Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. (1994) (31)
Primary Cutaneous Lymphoproliferative Disorders With Dual Lineage Rearrangement (2006) (31)
Constitutive and Interleukin-7/Interleukin-15 Stimulated DNA Binding of Myc, Jun, and Novel Myc-Like Proteins in Cutaneous T-Cell Lymphoma Cells (1999) (30)
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. (1998) (30)
Constitutive and interleukin-7/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells. (1999) (30)
Monoclonal antibody patterns in lymphomatoid papulosis. (1985) (30)
Evidence for cell‐mediated immune mechanisms in the pathology of pemphigus (1993) (30)
Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). (2000) (29)
Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. (2001) (29)
Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. (1992) (29)
The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. (1991) (28)
CO2 Laser Surgery for Extensive, Cauliflower-Like Anogenital Condylomata acuminata: Retrospective Long-Term Study on 19 HIV-Positive and 45 HIV-Negative Men (2002) (28)
Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. (2002) (28)
Method for simultaneous RNA and DNA isolation from biopsy material, culture cells, plants and bacteria. (1997) (28)
Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. (2000) (28)
Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. (1999) (28)
Circulating Sézary cells in the diagnosis of Sézary syndrome (quantitative and morphometric analyses). (1983) (28)
Apoptosis in CD30‐positive lymphoproliferative disorders of the skin (2005) (27)
A Rational Approach to the Therapy of Cutaneous T–Cell Lymphomas (1996) (27)
Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas (1991) (27)
Vaccination of melanoma patients with peptide-pulsed dendritic cells: 047 (1997) (27)
Contact allergies to topical corticosteroids: 10 cases of contact dermatitis (1991) (27)
Web‐based education (2016) (27)
Clinical and Therapeutic Aspects of Polymorphous Light Eruption (2003) (27)
Recent advances in cutaneous lymphomas. (2007) (27)
Multilesional Primary Cutaneous Diffuse Large B-Cell Lymphoma Responsive to Antibiotic Treatment (2001) (27)
Clinical Efficacy of Narrow-Band UVB (311 nm) Combined with Dithranol in Psoriasis (2000) (26)
Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate (2008) (26)
[Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]. (1990) (26)
A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30‐positive large‐cell pleomorphic lymphoma (2002) (26)
Cocaine-Related Stevens-Johnson Syndrome (2000) (26)
Therapeutic approaches in cutaneous lymphoma. (1994) (26)
Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. (1997) (25)
Benzidine Stain for the Histochemical Detection of Hemoglobin in Splinter Hemorrhage (Subungual Hematoma) and Black Heel (1995) (25)
Unusual combined sensitization to palladium and other metals (1991) (25)
Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. (1992) (25)
Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. (1995) (25)
Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma. (1981) (25)
Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. (1991) (25)
Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study. (1994) (24)
MANGANESE deficiency. (2022) (24)
Study of HHV‐8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions (2002) (24)
Recent advances in the understanding of cutaneous lymphoma * (1981) (24)
[Advances in cytochemical differentiation of cellular infiltrates into the skin]. (1974) (24)
T‐cell receptor β variable region (Vβ) usage in cutaneous T‐cell lymphomas (CTCL) in comparison to normal and eczematous skin (1996) (23)
Carpal Tunnel Syndrome with Ulcerous Skin Lesions (2000) (23)
Prevention Campaign against Skin Cancer (2002) (23)
Immunostaining in atypical fibroxanthoma of the skin. (1988) (23)
[Systemic therapy of metastatic melanoma]. (1999) (23)
CO2 Laser Treatment of Warts in Immunosuppressed Patients (2003) (23)
The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. (2001) (23)
Patterns of Cutaneous Lymphomas (1978) (22)
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. (2002) (22)
Management of venous leg ulcers. (1996) (22)
High Frequency of Melanoma-Associated Antigen or HLA Class I Loss Does Not Correlate with Survival in Primary Melanoma (2004) (22)
Expression of melanoma‐associated antigens in melanoma cell cultures (2005) (22)
Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. (1998) (22)
Monoclonal Rearrangement of the T Cell Receptor Gamma-Chain in Lichenoid Pigmented Purpuric Dermatitis of Gougerot-Blum Responding to Topical Corticosteroid Therapy (2002) (22)
Multifocal Fixed Drug Eruption to Paracetamol, Tropisetron and Ondansetron Induced by Interleukin 2 (2000) (21)
Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. (1990) (21)
Bioreactor Microcarrier Cell Culture System (Bio-MCCS) for Large-Scale Production of Autologous Melanocytes (2004) (21)
Sweet's syndrome associated with Salmonella typhimurium infection. (1991) (21)
Telemedicine and teledermatology. (2002) (21)
Cutaneous ossification in Albright's hereditary osteodystrophy. (1993) (21)
[Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis]. (1975) (21)
A Novel Bioreactor Microcarrier Cell Culture System for High Yields of Proliferating Autologous Human Keratinocytes (2006) (21)
Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia (2005) (21)
[Malignant atrophic papulosis (Köhlmeier-Degos disease)]. (1989) (20)
Cutaneous Ulceration after Injection of Polyethylene-Glycol-Modified Interferon Alpha Associated with Visual Disturbances in a Melanoma Patient (2000) (20)
Necrotizing granulomatosis of the breast (1997) (20)
High Yields of Autologous Living Dermal Equivalents Using Porcine Gelatin Microbeads as Microcarriers for Autologous Fibroblasts (2006) (20)
[Immunocytoma simulating chronic acrodermatitis atrophicans]. (1978) (20)
Surgical pearl: mini-incisions for the extraction of steatocystoma multiplex. (2001) (20)
Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. (1998) (20)
Strategies for Immunointerventions in Dermatology (1997) (19)
Micronodular Kaposi’s Sarcoma – A New Variant of Classic-Sporadic Kaposi’s Sarcoma (2004) (19)
Scalp dermatitis, distinctive hair abnormalities and atopic disease in the ectrodactyly—ectodermal dysplasia—clefting syndrome (1995) (19)
Histomorphology and cytomorphology of cutaneous B-cell lymphomas. (1984) (19)
The skin: an immunoreactive target organ during interleukin-2 administration? (1991) (19)
Morphological and functional differentiation and classification of cutaneous lymphomas. (1977) (19)
Cutaneous lymphomas and pseudolymphomas: newly described entities. (2002) (19)
Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients (2004) (19)
Subcutaneous Infection with Mycobacteriumabscessus in a Renal Transplant Recipient (2004) (18)
[Immunocytomas and immunoblastic lymphomas of the skin]. (1979) (18)
Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. (2003) (18)
Combined interferon-α and interleukin-2 as adjuvant treatment for melanoma (1998) (18)
Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis (2002) (18)
Scarring folliculitis in the ectrodactyly-ectodermal dysplasia-clefting syndrome. Histologic, scanning electron-microscopic and biophysical studies of hair. (1997) (18)
Significance of non‐lymphoid (‘accessory’) cells in malignant lymphomas and pseudolymphomas of the skin (1985) (18)
[Cutaneous side effects of gold therapy. Clinical and histologic results]. (1986) (17)
Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN‐γ in melanoma cell cultures established from CNS lesions (1999) (17)
Trichogerminoma: A Rare Cutaneous Adnexal Tumor with Differentiation toward the Hair Germ Epithelium (2002) (17)
The interleukin-2 receptor in lesions and serum of bullous pemphigoid (2004) (17)
Vulvitis granulomatosa and anoperineitis granulomatosa. (1991) (17)
Systemic involvement in mycosis fungoides. (2015) (17)
Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. (1991) (17)
Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group. (1994) (17)
‘EASIdig’ – A Digital Tool to Document Disease Activity in Atopic Dermatitis (2011) (16)
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. (1970) (16)
Cancer/testis antigen MAGE‐A4 expression pattern differs in epithelial skin tumors of organ‐transplant recipients and immunocompetent patients (2007) (16)
CLASSIFICATION AND DIFFERENTIATION OF CUTANEOUS LYMPHOMAS * (1975) (16)
Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures (2001) (16)
Acyclovir in lymphomatoid papulosis and mycosis fungoides. (1986) (15)
Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. (1993) (15)
Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin (1996) (15)
[Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. (1974) (15)
Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA (1996) (15)
Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease (1996) (15)
[Interleukin 2: immunologic background and clinical use in tumor therapy]. (1990) (15)
c-myc Is Not Useful as Prognostic Immunohistochemical Marker in Cutaneous Melanoma (1998) (14)
Significance of “accessory” cells in malignant lymphomas and pseudolymphomas of the skin (1986) (14)
Disseminated granuloma anulare: therapy with vitamin E topically. (1992) (14)
Irritant reactivity is a better risk marker for nickel sensitization than atopy. (1993) (14)
Mycosis fungoides and Sézary's syndrome show distinct histomorphological features. (1986) (14)
Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. (2000) (14)
[Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. (1992) (14)
CD44v6 is a marker for systemic spread in cutaneous T‐cell lymphomas (1995) (14)
Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. (2001) (14)
Relapsing eosinophilic perimyositis (1995) (14)
Granulomatous Mycosis Fungoides and Granulomatous Slack Skin (2008) (14)
Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma (2004) (14)
Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes. (1989) (13)
The Spectrum of Mesenchymal Skin Neoplasms Reflected by the New WHO Classification (2004) (13)
Eruptive hamartomatous clear-cell acanthomas. (1994) (13)
Bilateral Carpal Tunnel Syndrome as a Clue for the Diagnosis of Systemic Amyloidosis (2001) (13)
Human herpesvirus 8 (HHV‐8) in familial Kaposi's sarcoma (1999) (13)
Circulating Interleukin-2 Receptors Are a Group of Multimeric Proteins with Immunoreactivity for Interleukin-2 Receptor α, β, and γ Chains (1996) (13)
CUTANEOUS NON‐HODGKIN LYMPHOMA: RE‐EVALUATION OF HISTOLOGY USING ENZYMECYTOCHEMICAL AND IMMUNOLOGIC STUDIES (1978) (13)
Primary digital clubbing associated with palmoplantar keratoderma. (1997) (12)
Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. (1984) (12)
Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood (1999) (12)
Immunomodulators in the treatment of cutaneous lymphoma (1999) (12)
Follow-ups in Cutaneous Immunocytomas (1982) (12)
Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin (2005) (12)
[Psoriasis. A questionnaire study of 536 patients]. (1972) (12)
γ/δ Receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis (1992) (12)
The Anti-MAGE Antibody B57 as a Diagnostic Marker in Melanocytic Lesions (2004) (11)
High-grade malignant lymphoma arising from Sézary's syndrome. A case report. (1979) (11)
Prognostic significance of DNA cytometry in cutaneous malignant lymphomas (1991) (11)
[Lymphomatoid papulosis. Review and personal observation of 4 patients]. (1983) (11)
Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. (1998) (11)
Eyebrow reconstruction with free skin and hair-bearing composite graft. (1999) (11)
Report of the symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma. (1997) (11)
Letter to Dermatology (1999) (11)
Strategien zur Gentherapie des Melanoms (1995) (11)
Skin Cancers in Organ Transplant Recipients: Two Cases of Virus-Induced Neoplasms (2001) (10)
Idiopathic middermal elastolysis. (1993) (10)
Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry. (1990) (10)
New perspectives in experimental and clinical research for cutaneous T cell lymphomas. (1995) (10)
Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. (1991) (10)
Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies. (1987) (9)
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. (1996) (9)
Tumor‐infiltrating T cells in primary cutaneous B‐cell lympho‐proliferative disorders (2001) (9)
Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients. (1986) (9)
Ectodermal dysplasia with corkscrew hairs: observation of probable autosomal dominant tricho-odonto-onychodysplasia with syndactyly. (1994) (9)
Chédiak-Higashi syndrome: approaches in diagnosis and treatment. (1989) (9)
Tumour‐infiltrating lymphocytes in primary melanoma: functional consequences of differential IL‐2 receptor expression (1993) (9)
History of sexually transmitted infections (STI). (2012) (9)
Histopathologic and ultrastructural study of lupus‐like skin lesions in a patient with Bloom syndrome (1998) (9)
6.6. Teledermatology in Switzerland (2003) (9)
Combination of Bexarotene and Psoralen-UVA Therapy in a Patient with Mycosis fungoides (2004) (9)
Lack of expression of the recombination activating genes RAG‐1 and RAG‐2 in cutaneous T‐cell lymphoma: pathogenic implications (1997) (9)
Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature (2002) (9)
Allergic contact dermatitis from prednicarbate (1991) (9)
Occupational Contact Dermatitis Due to Glyoxal in Health Care Workers (1990) (9)
Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high‐dose tumour necrosis factor‐α and melphalan (1999) (9)
Acral sclerosis and leukoderma in a melanoma patient treated with interferon alpha and interleukin-2 (1995) (8)
Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia (1995) (8)
T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma (1993) (8)
Quantification of irritant contact dermatitis in vivo: comparison of the Dermatest® system with the evaporimeter (1991) (8)
The cellular stromal reaction in malignant melanoma (1972) (8)
Primary Cutaneous T-Cell-Rich B-Cell Lymphoma and Hodgkin’s Disease in a Patient with Gardner’s Syndrome (2000) (8)
Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate (1995) (8)
Uremic small-artery disease with medial calcification. A complication of chronic renal failure and benefit from parathyroidectomy (1995) (8)
[Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. (2001) (8)
Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. (1997) (8)
[Current therapy concepts in cutaneous T-cell lymphomas]. (1997) (7)
Dermatology online with interactive technology (DOIT). (2003) (7)
Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. (2002) (7)
The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis) (1977) (7)
Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. (1997) (7)
International Board Certification in Dermatopathology: A worldwide effort to raise standards in dermatopathology (2006) (7)
Collision dermatosis: angiolymphoid hyperplasia with eosinophilia developing within a congenital port wine nevus. (1993) (7)
Where are we today in the diagnosis of cutaneous lymphoma? (1989) (7)
A CD4+ CD56+ natural killer‐like T‐cell systemic lymphoma with haemorrhagic cutaneous manifestations (2001) (7)
Extracutaneous transformation into a high‐grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome (2006) (7)
[Pseudomonas aeruginosa folliculitis after epilation]. (1993) (7)
Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas (1996) (7)
Cowden-Syndrom (1995) (7)
[Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]. (1988) (7)
Quantitative analysis of lymphoid cells in myocosis fungoides, Sézary's syndrome and parapsoriasis en plaques (2004) (7)
Telemedicine in Europe. (2003) (7)
Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA (1998) (7)
[Erythroderma and alcohol abuse]. (1999) (7)
Anaphylaxis Induced by Topically Applied Bacitracin (1990) (7)
Distinct subtypes of subcutaneous T-cell lymphoma. (1994) (7)
Brief Primary cutaneous CD8 (cid:1) and CD56 (cid:1) T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2 (2004) (6)
Human herpesvirus 7 and Pityriasis rosea (1998) (6)
Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. (1996) (6)
Historic Treasures in a New Museum: Dermatologic and Surgical Wax Models (1995) (6)
Dyscrasias with "undetermined significance". (2005) (6)
Cutaneous T-cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment (1994) (6)
Teledermatology in Switzerland. (2003) (6)
[Congenital poikiloderma with verrucous hyperkeratosis. An unusual form of Thomson's syndrome?]. (1988) (6)
[Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. (1987) (6)
Primary cutaneous atypical histiocytosis with possible dissemination. (1985) (5)
HTLV-I positive primary cutaneous B-cell lymphoma (1986) (5)
An Improved Organ Culture for Regeneration of Pure Autologous Keratinocytes from Small Split-Thickness Skin Specimens (2004) (5)
[Local treatment of disseminated granuloma anulare with a vitamin E emulsion]. (1991) (5)
[Current pathogenetic aspects of Sézary syndrome and mycosis fungoides]. (2001) (5)
Soluble interleeukin‐2 receptors and cutaneous t‐cell lymphoma (1993) (5)
[Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment]. (1996) (5)
[Cytostatics and immunosuppressive agents in dermatology]. (1970) (5)
5.2.1. Dermatology Online with Interactive Technology (DOIT) (2003) (5)
Bexarotene and systemic disease progression in CTCL? (2006) (5)
[Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. (1996) (5)
International Board Certification in Dermatopathology: paving the way for the future (2004) (5)
Cutaneous polyarteritis nodosa. (1998) (5)
Intravenous single-dose ceftriaxone treatment of chancroid. (1991) (5)
Enzymecytochemical and immunocytological studies as a basis for the revaluation of the histology of cutaneous B-cell and T-cell lymphomas. (1977) (5)
Autoradiographic Pattern of Cell Proliferation in Cutaneous Malignant Lymphoma (1982) (5)
Fas Ligand Reduces Viability in Primary Melanoma Short-Term Cell Cultures More than in Metastatic Melanoma Short-Term Cell Cultures (2005) (5)
[The tumor suppressor gene p53 and its significance for dermatology]. (1994) (5)
Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. (2004) (5)
The Telemedical Information Society: doctors' playground or a contribution to the evolution of healthcare? (2003) (5)
[Dermatological aspects in prevention and treatment of the diabetic foot syndrome]. (1999) (5)
Non-recreational Pseudomonas aeruginosa folliculitis. Report of two cases and review of the literature (1993) (4)
HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. (2003) (4)
[Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy]. (1989) (4)
[Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. (1995) (4)
Kutane T-Zell-Lymphome (2003) (4)
Lepra vulgaris. History of Psoriasis (2014) (4)
Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. (1992) (4)
Diagnostic signs of cutaneous lymphomas (2001) (4)
[Histiocytosis X. An oligosymptomatic form of Hand-Schüller-Christian disease with a new form and possibilities of diagnosis]. (1984) (4)
Cutaneous Lymphomas: Unusual Cases (2001) (4)
Changes in color of the skin and systemic disease. (2019) (4)
Immunological Work Up (1981) (4)
Olaquindox-Induced Photoallergic Contact Dermatitis and Persistent Light Reaction (1990) (4)
Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. (1995) (4)
[Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]. (1990) (4)
[The red face]. (2004) (4)
Proteus syndrome@@@Proteus Syndrom (2003) (4)
Visceral Organs into the Skin , but Normal Extravasation into T Cell Migration + and CD 8 + Impaired CD 4 ShowDefective E-, P-, and L-Selectin Ligands Fucosyltransferase VII-Deficient Mice with and (2002) (4)
[Loose anagen hair]. (1992) (4)
Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin. (1978) (4)
Cultured Epithelial Autografts for the Management of a Chronic Pretibial Leg Ulcer due to Congenital Valvular Aplasia (1999) (4)
Formation of antibodies against recombinant interferon‐alpha during adjuvant immunotherapy in malignant melanoma (1994) (4)
Molecular defects in erythropoietic protoporphyria with terminal liver failure (1994) (4)
A progressive papular eruption on the chest and back. (2004) (4)
[Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. (2000) (4)
[1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients]. (1977) (4)
Mycosis fungoides – analysis of the duration of disease stages in patients who progress and the time point of high‐grade transformation (2007) (4)
Lymphokine-activated killer-cell traffic in metastatic melanoma (1991) (4)
[Actinobacillus actinomycetemcomitans isolated from a mycetoma (of the forearm)]. (1994) (4)
Prospective randomized multicenter trial on the outpatient use of subcutaneous interleukin 2 and interferon ??2b in high risk melanoma patients: 401 (1997) (3)
Pagetoid Reticulosis — A Rare Entity? (1982) (3)
[Specific cutaneous changes in Hodgkin's disease (author's transl)]. (1973) (3)
Sjögren-Lupus erythematodesÜberlappungssyndrom (1995) (3)
[Malignant lymphomas of the skin]. (1983) (3)
[Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. (1969) (3)
Ectrodactyly-ectodermal dysplasia-clefting syndrome with scalp dermatitis. (1993) (3)
[Nosologic relation of dyskeratosis follicularis (Darier) and pemphigus benignus chronicus familiaris (Hailey-Hailey). Position based on a case report]. (1985) (3)
191 AIDS, HIV infection and allergy (1988) (3)
Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma. (1994) (3)
[Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus]. (1993) (3)
Dermatosen durch Neuropathien (1983) (3)
[Sézary's syndrome. Case report]. (1975) (3)
Teledermatology – its place in modern skin healthcare worldwide (2020) (3)
Giant lichenification of the vulva with marked ulcerations. A case report. (1991) (3)
Skin diseases in Europe. Teledermatology. (2009) (3)
23 A prospective randomised multi-centre trial for the treatment of primary high-risk melanoma using s.c. interleukin-2 and interferon-alpha (1995) (3)
Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. (1984) (3)
[Histochemistry of capillaries in psoriasis vulgaris]. (1970) (3)
[T and B lymphocytes in skin changes of cutaneous lymphoma (author's transl)]. (1975) (3)
Retinoids 10 Years On (1990) (3)
[High-grade malignant mycosis fungoides with cytological transformation (author's transl)]. (1981) (3)
Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. (1988) (3)
Juvenile granulomatous cutaneous T cell lymphoma: a new entity in cutaneous lymphomas?: 24 (1997) (3)
Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in Guinea Pigs (1974) (3)
Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12? (2000) (3)
[Unilateral "nevoid" spider nevi]. (1993) (3)
Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas (1979) (3)
Non‐MHC‐Restricted T‐Cell Interaction with B Cells: Role of the T‐Cell Receptor (1992) (3)
Plasma cells accumulating around epidermal neoplasias. Immunoenzymatic staining of paraffin sections (1984) (3)
Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas. (1984) (3)
Therapy for cutaneous melanoma (1998) (3)
Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro (2004) (3)
Atlas of Dermatopathology (2018) (2)
Morphology of Cells (1983) (2)
[Strategies for gene therapy of melanoma]. (1995) (2)
Longitudinal study of surface antigen pattern in cutaneous T-cell lymphomas (1984) (2)
International board certification in dermatopathology: paving the way for the future. (2004) (2)
Classifications of Malignant Non-Hodgkin’s Lymphomas (1983) (2)
Cancers of the Skin (2002) (2)
Foreign body granuloma of the penis caused by occupational glass fibre exposure. (1997) (2)
[Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. (2001) (2)
[Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]. (1992) (2)
T‐zone lymphoma with cutaneous involvement: a case report and review of the literature (2002) (2)
Alkaline phosphatase positive lymphoma. (1984) (2)
German-Austrian Cutaneous Lymphoma Cooperative Study Group (1982) (2)
[Acquired (postinflammatory) dermatchalasis, dermatitis herpetiformis Duhring, celiac syndrome, dermatochalasis]. (1975) (2)
Kutane Lymphome (2004) (2)
[Prevalence of skin cancers in the Mosane region and in European countries of the same latitude]. (1989) (2)
[Immunologic phenotyping of cutaneous lymphomas]. (1986) (2)
Atypical Poorly Differentiated Cutaneous T-Cell Lymphoma with an Angiocentric Growth Pattern Presenting Histologically as Vasculitis (2005) (2)
Cutaneous immunoblastic T-cell lymphoma (2004) (2)
[Erosive pustulous dermatitis of the scalp]. (1987) (2)
2.1. Teleteaching Tools in Dermatology on the Web (2003) (2)
[Immunotherapy of melanoma]. (2000) (2)
[Acyclovir in mycosis fungoides and lymphomatoid papulosis]. (1986) (2)
Aent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment (2005) (2)
Proliferating cells in fibro-histiocytic tumors of the skin do not express monocyte-macrophage related antigens (1988) (2)
[Therapy of mycosis fungoides]. (1980) (2)
Deposition and Storage (2015) (2)
Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. (2002) (2)
Teleteaching tools in dermatology on the Web. (2003) (2)
AIDS, HIV-Infektion and allergische Reaktionen (1987) (2)
[Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. (1971) (2)
Microscopically Controlled Surgery in Malignant Dermatological Tumors (2007) (2)
Leukemic Lymphomas/Leukemias (1983) (2)
[Pagetoid skin infiltrates]. (1986) (2)
Functional expression of CCR3 but not of CCR7 in lymphogenic melanoma metastasis (2002) (2)
[Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas]. (1980) (2)
The influence of tretinoin on photodamaged human skin A biochemical, cytogenetical and histological evaluation over nine months (1994) (2)
Cutaneous Manifestations of Burkitt’s Lymphoma (1983) (1)
Clonality in sarcoidosis , granuloma annulare , and granulomatous mycosis fungoides (1)
[Skin symptoms in neurological diseases]. (1995) (1)
Book Review and New Books Received (2003) (1)
IL-15 AND IL-7 ARE GROWTH FACTORS FOR CUTANEUOS T CELL LYMPHOMA CELLS: 49 (1997) (1)
Small Lymphoid Cell Lymphomas with Band-like T Cell Pattern (Mycosis Fungoides Type) (1983) (1)
DIAGNOSTIC PROBLEMS IN MINIMAL LYMPHOPROLIFERATIVE SKIN INFILTRATES (1992) (1)
Seminars in diagnostic pathology. Introduction. (1991) (1)
Kontroversen in der Therapie kutaner Lymphome (1987) (1)
Weight of Decision-Making Impairs Clinical Assessment of Melanocytic Lesions (2007) (1)
[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]. (1997) (1)
Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma (2004) (1)
Exploring primary cutaneous B-cell lymphoma by microarray technology. (2003) (1)
[Current treatment methods in skin tumors]. (1992) (1)
New Trends in Allergy II (1986) (1)
[Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. (1976) (1)
Olaquindox-induced persistent light reaction treated by Escherichia coli filtrate (Colibiogene) (1995) (1)
[Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis]. (1993) (1)
[Malignant melanoma of the skin]. (1993) (1)
Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. (2001) (1)
[Modern tumor therapy as seen in melanoma]. (1996) (1)
Review articleImmunomodulators in the treatment of cutaneous lymphoma (1999) (1)
Extracutaneous clonal TcR-Beta rearrangement on cutaneous T-cell lymphoma (CTCL) and T-Pseudolymphomas (PSL) (1994) (1)
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. (1970) (1)
Clonal granulomatous infiltrates in Sézary’s syndrome (2001) (1)
02 High frequency of allelic deletion on 9p21 (p16 gene locus) in melanoma metastases of non-responders to peptide-pulsed dendritic cell vaccination (1999) (1)
[Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. (1970) (1)
Proliferation of CD 30 T-Helper 2 Lymphoma Cells Can Be Inhibited by CD 30 Receptor Cross-Linking with Recombinant CD 30 Ligand 1 (2003) (1)
Cutis marmorata teleangiectatica congenita (1990) (1)
Cutaneous pleomorphic T-cell lymphoma showing lineage cross-over of antigen receptor gene rearrangement (1996) (1)
Sensitization to Olive Oil (1991) (1)
[Overlap of Sjögren-lupus erythematosus syndrome]. (1995) (1)
Amcinonide-Induced Contact Dermatitis—Possibly Due to the Ketal Structure (1990) (1)
International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. (2005) (1)
EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer. (2002) (1)
Erythropoetische protoporphyrinämische Lichtdermatose (1970) (1)
[E-Learning in medicine: at the top or a flop]. (2008) (1)
[Eosinophilia-myalgia syndrome after L-tryptophan intake]. (1991) (1)
HPV 56 in verrucae of the hands and perianal condylomata acuminata of an immunosuppressed patient with Alport-syndrome: 91 (1997) (1)
[Cutaneous T-cell lymphomas]. (1978) (1)
Diminished natural killer cell activity in patients with mycosis fungoides can be partially restored by interleukin-2 (IL-2) (1989) (1)
Plasmacytoid Predendritic Cells Following Imiquimod Treatment (2005) (1)
Adjuvant immunotherapy in malignant melanoma: Formation of antibodies against recombinant interferon-alpha (1994) (1)
[Pemphigus foliaceus caused by penicillamine]. (1993) (1)
Atlas of Dermatopathology: Practical Differential Diagnosis by Clinicopathologic Pattern (2015) (1)
Cancers of the skin. Proceedings of the 8th World Congress on Cancers of the Skin, Zurich, Switzerland, 18th-21st July 2001. (2002) (1)
Der Ekzempatient in der Praxis (1990) (1)
functional consequencesofdifferential IL-2receptorexpression (1993) (1)
Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates (2004) (1)
[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. (1971) (1)
[Therapy of porphyrias]. (1972) (1)
Incidence of bone marrow involvement in cutaneous lymphoma (1987) (1)
Antimonyl potassium tartrate (APT) causes cell death of CTCL (cutaneous T cell lymphoma) cells (1998) (1)
Prevalence of Ureaplasma urealyticum in the urethra of men without urethritis in relation to clinical diagnosis. (1990) (1)
[Vaccination therapy of malignant melanoma]. (1999) (1)
The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas (2005) (0)
Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. (1993) (0)
DOWN REGULATION OF TAP-1/-2 BUT NOT OF LMP-2/-7 INDICATES POOR PROGNOSIS IN PRIMARY MELANOMA (1998) (0)
Interleukin-2 in Combination with Dacarbazine in the Treatment for Malignant Melanoma (1992) (0)
Contents Vol. 210, 2005 (2005) (0)
[Histologic study of lymph nodes in tumor resections--results of a survey of the German TNM Committee]. (1992) (0)
Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and first results with patients (1995) (0)
Enzyme cytochemical and immunocytological characterization of cutaneous lymphomas (1976) (0)
Contents Vol. 200, 2000 (2000) (0)
T-zone lymphoma with involvement of the skin (2001) (0)
Contents Vol. 202, 2001 (2001) (0)
ILDS Newsletter No. 20 (2011) (0)
Dermal-epidermal Junction (Interface) (2015) (0)
[The pathogenesis of psoriasis--new results]. (1992) (0)
Acknowledgement to Referees for Dermatology 2004 (2004) (0)
Acknowledgment to Referees for Dermatology 1995 (1995) (0)
Clonal Granulomatous Infiltrates in a Patient With Sezary's Syndrome: (1998) (0)
[Spread of tuberculosis in ornamental fishes]. (1983) (0)
Keyhole Limpet Hemocyanin (KLH)-pulsed dendritic cells induce longterm Th1-type immune response in patients with metastatic melanoma (1998) (0)
Erratum / Book Review (2001) (0)
Public education in skin cancer world-wide. (2002) (0)
[Immuno-intervention in cutaneous lymphomas]. (2000) (0)
[Therapy of porphyrias]. (1972) (0)
[History of the Munich Dermatology Society]. (1990) (0)
Cutaneous Manifestations of Hodgkin’s Disease (1983) (0)
Contents, Vol. 184, 1992 (1992) (0)
Characterization of peritumoral dendritic antigen-presenting cells (APCs) in sunlight induced skin cancers: 43 (1997) (0)
Metabolic Fatty Liver Disease (2009) (0)
Immunophenotypicevidence for a close relationship between lymphomatoidpapulosis and Hodgkin's disease (1990) (0)
Multilobated B-Cell Lymphoma of the Skin: a Variant of Follicular Center Cell Lymphoma (1990) (0)
Contents, Vol. 191, 1995 (1995) (0)
Subject Index Vol. 191,1995 (1995) (0)
Theprognosis ofprimary andmetastasising melanoma. Anevaluation of theTNM classification in2,495 patients (1992) (0)
Subject Index Vol. 190,1995 (1995) (0)
[Cutaneous lymphoma]. (2004) (0)
Reply (1997) (0)
Dermatopathology, Abstract 328–338, Study Group (2003) (0)
UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes. (1993) (0)
Expression of CD1 family molecules in primary and metastatic melanoma (2001) (0)
Reply (1999) (0)
[What is your diagnosis? Bilateral idiopathic calcification of the ear cartilages]. (1997) (0)
Acknowledgement to Referees for Dermatology 2002 (2002) (0)
Angiolymphoid hyperplasia with eosinophilia and clonal T-cell population (2001) (0)
Subject Index Vol. 200, 2000 (2000) (0)
Factor-VIII-Related Antigen is Present in Mast Cells (1990) (0)
Subject Index Vol. 200, 2000 (2000) (0)
[Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. (1973) (0)
Contents Vol. 209, 2004 (2004) (0)
[Local recurrent centroblastic lymphoma of the skin]. (1988) (0)
The Skin as a Target Organ During II-2 Administration (1994) (0)
Microenvironment and epidermotropism in cutaneous T cell lymphoma (CTCL): Cytokine and cellular dependency of human CTCL-lines generated in vitro (1998) (0)
Prognostic relevance of TNM-staging in cutaneous T-cell lymphomas (1986) (0)
[Problems, responsibility and goals in dermatopathology]. (1998) (0)
FURTHER EVIDENCE FOR INVOLVEMENT OF CELL DERIVED MEDIATORS IN LESION FORMATION OF BULLOUS PEMPHIGOID (1992) (0)
Cutaneous Lymphoma, Leukemia and Related Disorders (2010) (0)
Contents, Vol. 189, 1994 (1994) (0)
The expression and regulation of cell survival genes in cutaneous T cell lymphoma (CTCL) cells (1998) (0)
Methods and Criteria for Identification of Cells Occurring in Lymphomas and Related Diseases of the Skin (1983) (0)
Contents, Vol. 186, 1993 (1993) (0)
[The value of Gardnerella-vaginalis-culture in bacterial-vaginitis- score-confirmed bacterial vaginosis]. (1991) (0)
Palisaded Encapsulated Neuroma (1987) (0)
Preliminary Pages / Contents / Preface (2003) (0)
A New Histopathological Classification of Melanomas. A Survey and Reevaluation of 1690 Skin Melanomas: 58 (1997) (0)
Diseases of the Mononuclear-Phagocyte System: Tumors and Tumor-Like Disorders (1983) (0)
Hypo- and hyperpigmented areas in incontinentia pigmenti. Reply by Zillikens et al. (1992) (0)
Vaccination of cutaneous T-cell lymphoma patients with tumor lysate pulsed dendritic cells (2002) (0)
[LEOPARD syndrome]. (1979) (0)
Mycetoma of the upper arm following infection by Actinobacillus actinomycetemcomitans (1994) (0)
81st Annual Meeting of the Swiss Society for Dermatology and Venereology (2000) (0)
[Enzyme cytochemical and immunocytologic studies of mycosis fungoides]. (1977) (0)
[The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. (1969) (0)
CHARACTERIZATION OF MONONUCLEAR CELLS AT THE BASEMENT MEMBRANE ZONE IN BULLOUS PEMPHIGOID (1992) (0)
Meeting of the Belgian Royal Society for Dermatology and Syphiligraphy (1992) (0)
Contents Vol. 205, 2002 (2002) (0)
[To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)]. (2012) (0)
Subject Index Vol. 211, 2005 (2005) (0)
Contents, Vol. 169, 1984 (1984) (0)
Precursor B-lymphoblastic lymphoma with skin involvement (2001) (0)
Absence of mutations in the p53 tumour suppressor gene in malignant melanoma (1993) (0)
Acknowledgement to Referees for Dermatology 2005 (2005) (0)
[In memoriam: Prof. Dr. Dr. h.c. Urs Walter Schnyder: 7 February 1923-21 October 2012]. (2013) (0)
77th Annual Meeting of the Swiss Society for Dermatology and Venereology (1995) (0)
[Cutaneous lymphomas, and pseudolymphomas. Immunocytological, enzymocytochemical and electron microscopical studies (authors transl)]. (1976) (0)
Primary cutaneous CD8+ T-cell lymphoma (mycosis fungoides-like type) (2001) (0)
Imiquimod Treatment In Vivo Induces Massive Skin Recruitment and Activation of Plasmacytoid Dendritic Cells in a Disease-Independent Manner (2004) (0)
[Cytochemical studies on cellular stroma reaction in melanoma]. (1972) (0)
Selective loss of HLA-I A- and B-allospecificities in melanoma: 480 (1997) (0)
[Cutaneous neoplasms]. (2003) (0)
[Persistent facial swelling of uncertain origin]. (1998) (0)
[Cytostatic and immunosuppressive treatment of dermatologic diseases]. (1971) (0)
Miscellaneous Diseases Clinically Resembling or Related to Cutaneous Lymphomas or Pseudolymphomas (1983) (0)
Acknowledgment to Referees for Dermatology (2000) (0)
Differentialdiagnose der Lippenschwellungen (1999) (0)
73rd Annual Meeting of the Swiss Society for Dermatology and Venerology (1992) (0)
Subject Index Vol. 189,1994 (1994) (0)
Pathogenese kutaner T-Zell-Lymphome (2000) (0)
[Herr Professor and Dr. of Medicine Urs Walter Schnyder on his 80th birthday]. (2003) (0)
Mild hyperphenylalaninemia (2020) (0)
Small and Mixed Small and Large Lymphoid Cell Lymphomas with Nodular B Cell Pattern (Reticulosis Type) (1983) (0)
Patterns of Cellular Infiltrates in Cutaneous Lymphomas (1983) (0)
Morphological, Immunological, and Clinical Features of Cutaneous CD30-Positive Large-Cell Tumors (1989) (0)
International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. (2005) (0)
[News on TNM consultation activity of the German Language Committee]. (1990) (0)
Shedding of Interleukin-2 Receptor in Cutaneous Lymphomas: An Effective Mechanism to Circumvent Immunosurveillance? (1994) (0)
An in vivo mouse lymphoma model for photopheresis (1998) (0)
[Report of the German-Speaking TNM Committee]. (1993) (0)
INDEX (2007) (0)
2 Local immunotherapy in melanoma using biological response modifiers and gene transfer (2004) (0)
[Malignant lymphoma of the skin]. (1993) (0)
Cutaneous B-cell lymphoma with fibrohistiocytic reaction: 9 cases.: 51 (1997) (0)
Sensitivity to Oxidative Stress in the Photosensitivity Dermatitis / Actinic Reticuloid Syndrome (2009) (0)
NoEvidence ofHTLV-I Proviral Integration in Lymphoproliferat ive (1997) (0)
Subject Index Vol. 202, 2001 (2001) (0)
[Controversial aspects of stage I skin melanomas]. (1992) (0)
6.4. Telemedicine in Europe (2003) (0)
[Recurrent eyelid tumor in necrotizing panniculitis]. (1992) (0)
Testing CTCL cell lines for the expression of the rag genes (1994) (0)
Diffuse large B-cell lymphoma with cutaneous and ocular involvement (2006) (0)
Pilomatrixcarcinoma with Distant Metastasis (1990) (0)
UVA suppresses shedding of ICAM-1 from interferon-γ (IFN-γ)-pretreated transformed keratinocytes (2004) (0)
Report from the president (V) 1992-1994. (1995) (0)
Serum Levels of IL-2 and Soluble IL-2 Receptor in Cutaneous Lymphoma (1990) (0)
T-Zone Lymphoma with Involvement of Skin and Lymph Node. (1997) (0)
European Organization of Research and Treatment of Cancer (EORTC) Lymphomas (ISCL) and the cutaneous lymphoma task force of the Sézary syndrome: a proposal of the International Society for Cutaneous Revisions to the staging and classification of mycosis fungoides and (2009) (0)
Cutaneous T-cell lymphoma with clonal B-cell reaction: 25 (1997) (0)
Demonstration of Immunologic Markers for the Identification of Lymphoid Cells in Cutaneous Infiltrates (1983) (0)
Proteus syndrome. (2003) (0)
Subject Index Vol. 201, 2000 (2000) (0)
Phase I/II study of adenovirus-interferon-γ (TG1042) in primary cutaneous lymphomas (CL). (2004) (0)
Monocyte derived dendritic cells mature in response to the TLR7 agonist loxoribine (2004) (0)
Trisomy X (2020) (0)
Subject Index Vol. 205, 2002 (2002) (0)
Immune escape mechanisms in melanoma patients vaccinated with peptide pulsed dendritic cells (1998) (0)
What is new in the treatment of cutaneous lymphomas (1998) (0)
Malignant histiocytic disorders of the skin. (1981) (0)
13 Prospective-randomized study on the adjuvant use of s.c. IL-2 and s.c. IFNα2b in high-risk melanoma patients (1999) (0)
[Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. (1977) (0)
Applications of molecular virology to modern dermatopathology. (2001) (0)
NFkB gene family member expression in CTCL skin lesions and IKB downregulation in CTCL cell lines (2001) (0)
[Perspective of cutaneous lymphoma reserach]. (2006) (0)
Contents Vol. 201, 2000 (2000) (0)
[Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. (1970) (0)
Short Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8 1 and CD56 1 Cutaneous Lymphomas (2001) (0)
Subtyping of cutaneous follicular lymphoproliferative B-cell infiltrates (1993) (0)
Cancer of the Skin : Proceedings of the 8th World Congress (2002) (0)
Pigmentary disorders associated with nutritional deficiency states. (1989) (0)
[Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. (1974) (0)
Precursor Lymphoblastic Leukemia=lymphoma (2005) (0)
Large Lymphoid Cell Lymphomas with Diffuse Non-B,Non-T Cell Pattern (Reticulo- and Lymphosarcoma Type) (1983) (0)
[Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. (2007) (0)
Characterization of CD3 + and CD56 + Lymphocyte Subsets in Melanoma Patients After In Vivo Recombinant Interleukin-2 Administration (1992) (0)
A Special Issue of Dermatology Dedicated to Theo Rufli (2005) (0)
What’s new in the treatment of melanoma? (2000) (0)
·P-16 Interrater variability in pathological classification: Impact on prognosis of non-hodgkin lymphoma (1990) (0)
[Chemosurgery of basaliomas]. (1974) (0)
[Gammaglobulins and allergy. Clinical results of a controlled study with standard human IgG and placebo in pollinosis]. (1983) (0)
Functional expression of the eotaxin receptor CCR3 in a subset of cutaneous T cell lymphoma (2001) (0)
Contents, Vol. 190, 1995 (1995) (0)
CD8+ cutaneous T-cell lymphoma with an indolent course (2006) (0)
DermARTologie/DermARTtology (2022) (0)
A misnomer in the histopathological diagnosis of melanoma: acro-lentiginous melanoma should be called acanthotic-lentiginous melanoma (1995) (0)
7 Specific immunotherapy for melanoma: pitfalls and perspectives (1999) (0)
Enzyme Cytochemistry: Diagnostically Relevant Facts (1983) (0)
[Atypical fibroxanthoma]. (1980) (0)
A CLA-positiv and L-selectin-negativ cutaneous T-cell lymphoma with transition of a skin homing to a lymphnode homing phenotype after treatment with extra-corporeal photopheresis (ECP) (1998) (0)
Subject Index Vol. 209, 2004 (2004) (0)
Cancer/testis antigens in cutaneous T cell lymphomas. (2001) (0)
[Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. (1982) (0)
Coexpression of CD 40 and CD 40 Ligand in Cutaneous T-Cell Lymphoma ( Mycosis Fungoides ) 1 (2001) (0)
Contents, Vol. 187, 1993 (1993) (0)
Contents Vol. 200, 2000 (2000) (0)
Prognoseevaluation mittels Immunhistologie (2002) (0)
Jessner-Kanof's Lymphocytic Infiltration of the Skin: A Classification Based on an Immunohistochemical Study: 93 (1997) (0)
[Telemedicine in dermatology 2003: a review]. (2004) (0)
Contents Vol. 211, 2005 (2005) (0)
Specific Immune Response Against Melanoma: Analysis at a Clonal Level (1994) (0)
Subject Index Vol. 210, 2005 (2005) (0)
[Unusual manifestation of scleroderma of the trunk]. (1990) (0)
Hodgkinʼs Disease Followed by Lymphomatoid Papulosis: Immunological Evidence Relating Both Conditions (1989) (0)
Acknowledgement to Referees for Dermatology 1994 (1994) (0)
Contents, Vol. 181, 1990 (1990) (0)
[Reticulosis of the skin - a heterogenic group of diseases]. (1980) (0)
Ulcerative Lymphomatoid Panniculitis: A Variant of Regressing Atypical Histiocytosis? (1989) (0)
Conference report3rd Sofia-Zürich day for Dermatology and Venereology: May 10, 1995, Sofia, Bulgaria (1995) (0)
Clinical results of total skin electron-beam radiation therapy for cutaneous T-cell lymphoma in advanced stages (1993) (0)
Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Günter Burg?

Günter Burg is affiliated with the following schools: